Cargando…

Etiology and Treatment of Growth Delay in Noonan Syndrome

Noonan syndrome is characterized by multiple phenotypic features, including growth retardation, which represents the main cause of consultation to the clinician. Longitudinal growth during childhood and adolescence depends on several factors, among them an intact somatotrophic axis, which is charact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez, Fernando, Gaete, Ximena, Cassorla, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8212989/ https://www.ncbi.nlm.nih.gov/pubmed/34149626 http://dx.doi.org/10.3389/fendo.2021.691240

Ejemplares similares

Growth in Children With Noonan Syndrome and Effects of Growth Hormone Treatment on Adult Height
por: Libraro, Annachiara, et al.
Publicado: (2021)

Editorial: Endocrine aspects of Noonan syndrome and related syndromes
por: Radetti, Giorgio, et al.
Publicado: (2023)

GH Responsiveness in Children With Noonan Syndrome Compared to Turner Syndrome
por: Dahlgren, Jovanna, et al.
Publicado: (2021)

Abnormalities of pubertal development and gonadal function in Noonan syndrome
por: Patti, Giuseppa, et al.
Publicado: (2023)

Lipid profile in Noonan syndrome and related disorders: trend by age, sex and genotype
por: Tamburrino, Federica, et al.
Publicado: (2023)

Skeletal defects and bone metabolism in Noonan, Costello and cardio-facio-cutaneous syndromes
por: Papadopoulou, Anna, et al.
Publicado: (2023)

Genotypic Findings in Noonan and Non-Noonan RASopathies and Patient Eligibility for Growth Hormone Treatment
por: Carcavilla, Atilano, et al.
Publicado: (2023)

Inside the Noonan “universe”: Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns
por: Stagi, Stefano, et al.
Publicado: (2022)

Growth, Endocrine Features, and Growth Hormone Treatment in Noonan Syndrome
por: Dahlgren, Jovanna, et al.
Publicado: (2022)

Tegumentary manifestations of Noonan and Noonan-related syndromes
por: Quaio, Caio Robledo D'Angioli Costa, et al.
Publicado: (2013)

Noonan syndrome
por: van der Burgt, Ineke
Publicado: (2007)

Growth hormone therapy in patients with Noonan syndrome
por: Seo, Go Hun, et al.
Publicado: (2018)

Transcriptional Hallmarks of Noonan Syndrome and Noonan-Like Syndrome with Loose Anagen Hair
por: Ferrero, Giovanni Battista, et al.
Publicado: (2012)

Noonan syndrome and related disorders: Alterations in growth and puberty
por: Noonan, Jacqueline A.
Publicado: (2006)

Effectiveness of growth hormone therapy in children with Noonan syndrome
por: Seok, Eun mi, et al.
Publicado: (2020)

Cardiovascular safety of growth hormone treatment in Noonan syndrome: real-world evidence
por: Romano, Alicia, et al.
Publicado: (2021)

Klotho Gene and Protein in Human Placentas According to Birth Weight and Gestational Age
por: Iñiguez, Germán, et al.
Publicado: (2019)

Recognition Memory in Noonan Syndrome
por: Costanzo, Floriana, et al.
Publicado: (2021)

Clinical manifestations of Noonan syndrome
por: Digilio, MC, et al.
Publicado: (2001)

Development of disease-specific growth charts in Turner syndrome and Noonan syndrome
por: Isojima, Tsuyoshi, et al.
Publicado: (2017)

Growth Hormone Deficiency in a Child with Neurofibromatosis-Noonan Syndrome
por: Vurallı, Doğuş, et al.
Publicado: (2016)

Syndromic and non-syndromic etiologies causing neonatal hypocalcemic seizures
por: Huang, Yi-Chieh, et al.
Publicado: (2022)

The other side of Turner's: Noonan's syndrome
por: Agarwal, Pankaj, et al.
Publicado: (2013)

Noonan syndrome – a new survey
por: Tafazoli, Alireza, et al.
Publicado: (2016)

Personality and Psychopathology in Adults with Noonan Syndrome
por: Roelofs, Renée L., et al.
Publicado: (2019)

Noonan syndrome: improving recognition and diagnosis
por: Zenker, Martin, et al.
Publicado: (2022)

A Role for Oxytocin in the Etiology and Treatment of Schizophrenia
por: Rich, Megan Elizabeth, et al.
Publicado: (2015)

Five-year response to growth hormone in children with Noonan syndrome and growth hormone deficiency
por: Zavras, Niki, et al.
Publicado: (2015)

Noonan syndrome: rhGH treatment and PTPN11 mutation
por: Wu, Xian, et al.
Publicado: (2023)

Correlation between genetic heterogeneity and variability for response to growth hormone in Noonan syndrome
por: Shin, Young-Lim
Publicado: (2019)

Effect of Growth Hormone Therapy in Patients with Noonan Syndrome: A Retrospective Study
por: Apperley, Louise Jayne, et al.
Publicado: (2020)

Factor XIII Deficiency Associated With Noonan Syndrome
por: Kharel, Zeni, et al.
Publicado: (2021)

Pragmatic language impairment in children with Noonan syndrome
por: Selås, Magnhild, et al.
Publicado: (2016)

Multifocal Pigmented Villonodular Synovitis in the Noonan Syndrome
por: Miri, Othmane, et al.
Publicado: (2018)

OR21-03 Dose Responsiveness Of LUM-201 As Measured By Acute GH Response And IGF-1 And Annualized Height Velocity (AHV) Measured At 6 Months In The Interim Analysis Of The OraGrowtH212 Study In Idiopathic Pediatric Growth Hormone Deficiency (iPGHD)
por: Cassorla, Fernando, et al.
Publicado: (2023)

The Growth Characteristics of Patients with Noonan Syndrome: Results of Three Years of Growth Hormone Treatment: A Nationwide Multicenter Study
por: Şıklar, Zeynep, et al.
Publicado: (2016)

Recurrent implantation failure: A comprehensive summary from etiology to treatment
por: Ma, Junying, et al.
Publicado: (2023)

Rosette forming glioneuronal tumor in association with Noonan syndrome: pathobiological implications
por: Karafin, M., et al.
Publicado: (2011)

Current Understanding of the Etiology, Symptomatology, and Treatment Options in Premature Ovarian Insufficiency (POI)
por: Ishizuka, Bunpei
Publicado: (2021)

Manic and Depressive Symptoms in Children Diagnosed with Noonan Syndrome
por: Alfieri, Paolo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_huf5449njtkdupht155dv03nit